BVT Call 35 FRE 21.02.2025/ DE000VC9Z1T6 /
23/01/2025 19:45:21 | Chg.+0.750 | Bid21:58:12 | Ask21:58:12 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.320EUR | +47.77% | - Bid Size: - |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | 35.00 EUR | 21/02/2025 | Call |
GlobeNewswire
24/04/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil